The Cooper Companies, Inc. · NASDAQ:COO
The Cooper Companies — Cooper Companies — Merger or Acquisition (June 2012)
6 slides from The Cooper Companies's merger presentation, Jun 4, 2012
Slide 1: Tender Offer for Origio
Exhibit 99.3 TM A Quality of Life Company Tender Offer for Origio June 4, 2012
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995, including all revenue and earnings per share guidance, statements regarding anticipated closing of a transaction and the terms of a transaction, and ot
Slide 3: Origio Overview
Tender Offer for Origio Origio Overview Company Description Founded in 1987, Denmark-based Origio develops, manufactures and distributes highly specialized products that target in vitro fertilization (IVF) treatment with a goal to make fertility treatment safer, more efficient and convenient 1 #1 ma
Slide 4: Attractive Market Opportunity
Attractive Market Opportunity 1 GlobalIVFMarketSize(2011E): Global IVF Market Approx. $223M, up 12% YoY driven by 1 By Competitor geographic expansion Geographically Diversified Global Market: Other CSI (Sage) 11% Top Markets Include: U.S./Canada, 7% Japan, China, India, France Irvine Origio 11% 32%
Slide 5: Strategic Rationale
Tender Offer for Origio Strategic Rationale Strengthens CooperSurgical’s women’s healthcare franchise by providing significant scale to existing Fertility business Global market with strong growth characteristics Recession resistant product portfolio Limited reimbursement risk (US is primarily priva
Slide 6: Key Offer Terms
Tender Offer for Origio Key Offer Terms Purchase Price NOK 28 per share all cash offer – US$189M total purchase price (approx. $151 million equity and $38 million net debt) Financing Available off-shore cash and credit facilities EPS Impact Excluding one-time charges, neutral to fiscal 2012 EPS Excl